buformin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antihyperglycaemics, phenformin derivatives | 423 | 692-13-7 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 0.20 | g | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| Vd (Volume of distribution) | 1.84 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 6.58 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| fu (Fraction unbound in plasma) | 0.90 % | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 4.62 hours | Lombardo F, Berellini G, Obach RS |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | A10BA03 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Biguanides |
| CHEBI has role | CHEBI:22587 | antiviral agents |
| CHEBI has role | CHEBI:35526 | antidiabetic |
| CHEBI has role | CHEBI:35610 | antineoplastic agents |
| CHEBI has role | CHEBI:132992 | radiosensitizing agents |
| CHEBI has role | CHEBI:176497 | geroprotectors |
| MeSH PA | D007004 | Hypoglycemic Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Diabetes mellitus type 2 | indication | 44054006 | DOID:9352 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 11.6 | Basic |
| pKa2 | 3.6 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D00595 | KEGG_DRUG |
| C0006359 | UMLSCUI |
| CHEBI:3209 | CHEBI |
| BFR | PDB_CHEM_ID |
| CHEMBL39736 | ChEMBL_ID |
| DB04830 | DRUGBANK_ID |
| D002026 | MESH_DESCRIPTOR_UI |
| 2468 | PUBCHEM_CID |
| 2004 | INN_ID |
| 1190-53-0 | SECONDARY_CAS_RN |
| W2115E9C7B | UNII |
Pharmaceutical products:
None